Concourse Financial Group Securities, Inc. Replimune Group, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

29 transactions

Quarter	Operation	Price Per share
Q2 2025 Aug 12, 2025	BUY	$6.92 - $10.38 $0 - $0
Q1 2025 May 14, 2025	BUY	$9.75 - $14.31 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$10.54 - $14.93 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$8.09 - $11.23 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$5.01 - $9.46 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$6.87 - $9.31 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$6.75 - $16.18 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$15.96 - $22.18 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$15.96 - $22.18 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$15.65 - $24.1 $0 - $0
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$17.09 - $27.91 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$15.6 - $21.15 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$13.32 - $19.98 $0 - $0
Q1 2022 May 09, 2022	BUY	$15.24 - $29.75 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$25.43 - $34.25 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$28.98 - $39.54 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$28.5 - $39.37 $0 - $0
Q1 2021 May 13, 2021	BUY	$30.22 - $45.57 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$23.5 - $52.65 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$18.85 - $27.0 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$9.76 - $25.95 $0 - $0
Q1 2020 May 13, 2020	BUY	$8.9 - $19.08 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$11.61 - $17.21 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$10.01 - $16.87 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$12.51 - $17.28 $0 - $0
Q1 2019 May 15, 2019	BUY	$10.26 - $16.24 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$9.97 - $15.57 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$14.99 - $22.14 $0 - $0

Others Institutions Holding REPL

# of Institutions

195

Shares Held

79.7M

Call Options Held

2.06M

Put Options Held

2.86M

Baker Bros. Advisors LP New York, NY

11M
Shares

$91.8 Million
1.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

10.8M
Shares

$89.9 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.71M
Shares

$39.2 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

4.66M
Shares

$38.8 Million
5.27% of portfolio
Fcpm Iii Services B.V. Naarden, P7

3.91M
Shares

$32.5 Million
9.84% of portfolio

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $410M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account